The financing round was co-led by Boehringer Ingelheim Venture Fund and Parkwalk Advisors, with participation from Tencent and Oxford University Innovation Fund.
"Over the past decade Brainomix has created the market for stroke AI imaging. As a spin-out from the University of Oxford it is an example of the UK's world-leading strengths in life sciences and AI-enabled medtech, combining expertise in clinical care and software development with more than 150 years' experience in the field across its leadership team."
The Oxford Science Enterprises-led round will support US expansion and continued domestic growth in healthcare.
"I’m delighted our investors have again demonstrated their belief in the vast potential that Navenio can bring by ensuring ‘right person, right place, right time’. Artificial intelligence is one of many technologies making a real-world impact in the health sector, and this investment enables the company to rapidly spearhead international digital transformation."
The investment round was led by QVentures with backing from international investors to drive expansion and product development.
"Following the UK government’s call for businesses to do their part in tackling climate change, we’re proud to be supporting a company that is working to positively impact this goal. Alectro will help companies create a more sustainable world for future generations."
Venturian Funding and Investment Group has backed the data firm to accelerate its global growth.
"We’ve been talking with the Venturian team for some time and we’re delighted to be working with them not only to consolidate our position in the UK, but to expedite our plans for international expansion. The Data City has won a series of new clients this year, and our platform is going from strength to strength as we look forward to 2022."
